DDO-3055

N/A

Report date: 2026/05/11 20:01:57
NME

Base Information

Drug NameDDO-3055
Drug Alias NameDDO-3055
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHypoxia-inducible factor prolyl hydroxylase inhibitors
TargetsHypoxia-inducible factor prolyl hydroxylase
Therapy Area/IndicationsAnemiaRenal Insufficiency, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangsu Hengrui Medicine Co LtdSuzhou Suncadia Biopharmaceuticals Co LtdChina Pharmaceutical University
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesSuzhou Suncadia Biopharmaceuticals Co LtdJiangsu Hengrui Medicine Co LtdChina Pharmaceutical University
Inactive CompaniesN/A
Active IndicationsAnemia
Inactive IndicationsRenal Insufficiency, Chronic

Other Information

ATC CodeN/A
Related LinksN/A